By Catherine Eckford (European Pharmaceutical Review)2024-02-27T16:42:18
The biomanufacturing facility has been designed to help Amgen meet its target of carbon neutrality in all its operations by 2027, according to the company.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-02-09T10:00:00 2026-02-09T11:00:00
Sponsored by Emerson
2025-05-19T09:58:00
Sponsored by bioMérieux, Entegris and Cencora, By European Pharmaceutical Review
2025-10-08T07:00:00
Sponsored by Entegris
2026-05-13T14:00:00 2026-05-13T15:00:00
Sponsored by Thermo Fisher Scientific
2025-06-11T13:00:00
Sponsored by Rapid Micro Biosystems
2025-06-03T13:35:00
Sponsored by bioMérieux, By European Pharmaceutical Review
Site powered by Webvision Cloud